BMY (STOCKS)
Bristol-Myers Squibb Co.
$59.988200
-0.871800 (-1.43%)
Prev close: $60.860000
Company Information
- Exchange
- XNYS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Christopher S. Boerner
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $121,982.14M
- Employees
- 34,100
- P/E (TTM)
- 17.59
- P/B (TTM)
- 6.68
- Dividend Yield
- 409.14%
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
6
Strong Buy
8
Buy
18
Hold
2
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$1.26 | $1.13 | +0.1335 | +11.85% |
|
Sep 2025 (Q3)
|
$1.63 | $1.52 | +0.1056 | +6.93% |
|
Jun 2025 (Q2)
|
$1.46 | $1.08 | +0.3789 | +35.05% |
|
Mar 2025 (Q1)
|
$1.80 | $1.51 | +0.2920 | +19.36% |
Financial Statements
| Revenues | $48.03B |
| Benefits Costs and Expenses | $40.00B |
| Cost Of Revenue | $14.65B |
| Costs And Expenses | $40.00B |
| Gross Profit | $33.38B |
| Operating Expenses | $25.35B |
| Selling, General, and Administrative Expenses | $7.22B |
| Research and Development | $10.56B |
| Other Operating Expenses | $7.57B |
| Operating Income/Loss | $8.03B |
| Income/Loss Before Equity Method Investments | $8.04B |
| Income/Loss From Continuing Operations After Tax | $6.05B |
| Income/Loss From Continuing Operations Before Tax | $8.03B |
| Income/Loss From Equity Method Investments | -$44.00M |
| Income Tax Expense/Benefit | $1.99B |
| Income Tax Expense/Benefit, Deferred | -$1.36B |
| Net Income/Loss | $6.05B |
| Net Income/Loss Attributable To Noncontrolling Interest | $7.00M |
| Net Income/Loss Attributable To Parent | $6.04B |
| Net Income/Loss Available To Common Stockholders, Basic | $6.04B |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | $2.97 |
| Diluted Earnings Per Share | $2.97 |
| Basic Average Shares | 2,035,000,000 |
| Diluted Average Shares | 2,040,000,000 |
| Assets | $96.89B |
| Current Assets | $35.63B |
| Accounts Receivable | $11.42B |
| Inventory | $2.76B |
| Other Current Assets | $21.45B |
| Noncurrent Assets | $61.26B |
| Fixed Assets | $7.35B |
| Intangible Assets | $20.47B |
| Other Non-current Assets | $33.45B |
| Liabilities | $78.29B |
| Current Liabilities | $28.14B |
| Accounts Payable | $4.29B |
| Wages | $1.16B |
| Other Current Liabilities | $22.69B |
| Noncurrent Liabilities | $50.15B |
| Long-term Debt | $48.72B |
| Other Non-current Liabilities | $1.44B |
| Equity | $18.60B |
| Equity Attributable To Noncontrolling Interest | $48.00M |
| Equity Attributable To Parent | $18.55B |
| Liabilities And Equity | $96.89B |
| Net Cash Flow From Operating Activities | $16.62B |
| Net Cash Flow From Operating Activities, Continuing | $16.62B |
| Net Cash Flow From Investing Activities | -$2.87B |
| Net Cash Flow From Investing Activities, Continuing | -$2.87B |
| Net Cash Flow From Financing Activities | -$5.96B |
| Net Cash Flow From Financing Activities, Continuing | -$5.96B |
| Exchange Gains/Losses | $43.00M |
| Net Cash Flow | $7.83B |
| Net Cash Flow, Continuing | $7.79B |
| Comprehensive Income/Loss | $6.00B |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $7.00M |
| Comprehensive Income/Loss Attributable To Parent | $5.99B |
| Other Comprehensive Income/Loss | -$45.00M |